Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvo

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
American Journal of Hematology|November 19, 2016
Excess mortality in the myelodysplastic syndromesMeritxell Nomdedeu, Arturo Pereira, Fernando Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
Leukemia & Lymphoma|December 31, 2021
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromesSílvia Saumell, Miranda Fernández-Serrano, Alba Mesa, et al.
Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.
Blood|October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemiaPau Abrisqueta, Neus Villamor, María José Terol, et al.
Cancers|July 27, 2022
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)Anna Puiggros, Silvia Ramos-Campoy, Joanna Kamaso, et al.
The American Journal of Surgical Pathology|March 14, 2017
LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell LymphomasLuis Colomo, Ivonne Vazquez, Natalia Papaleo, et al.
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
American Journal of Hematology|November 19, 2016
Excess mortality in the myelodysplastic syndromesMeritxell Nomdedeu, Arturo Pereira, Fernando Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
Leukemia & Lymphoma|December 31, 2021
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromesSílvia Saumell, Miranda Fernández-Serrano, Alba Mesa, et al.
Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.
Blood|October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemiaPau Abrisqueta, Neus Villamor, María José Terol, et al.
Cancers|July 27, 2022
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)Anna Puiggros, Silvia Ramos-Campoy, Joanna Kamaso, et al.
The American Journal of Surgical Pathology|March 14, 2017
LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell LymphomasLuis Colomo, Ivonne Vazquez, Natalia Papaleo, et al.
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Pageof 6